Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?
- 29 February 2008
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 20 (1), 105-110
- https://doi.org/10.1016/j.coi.2007.10.007
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Predicting peptides bound to I‐Ag7 class II histocompatibility molecules using a novel expectation‐maximization alignment algorithmProteomics, 2007
- Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificityJCI Insight, 2005
- Nonstimulatory peptides contribute to antigen-induced CD8–T cell receptor interaction at the immunological synapseNature Immunology, 2005
- Agonist/endogenous peptide–MHC heterodimers drive T cell activation and sensitivityNature, 2005
- Frontline: Self-peptides that bind with low affinity to the diabetes-associated I-Ag7 molecule readily induce T cell tolerance in non-obese diabetic miceEuropean Journal of Immunology, 2004
- Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune DiabetesThe Journal of Experimental Medicine, 2002
- Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD miceEuropean Journal of Immunology, 1995
- Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8International Immunology, 1994
- Peptides Presented to the Immune System by the Murine Class II Major Histocompatibility Complex Molecule I-A dScience, 1992
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991